世界の認知症治療市場は大幅な成長が見込まれており、2023年には166億9,000万米ドルに達すると推定され、2024年から2032年の予測期間にわたって年平均成長率（CAGR）8.0％で拡大すると予測されています。この急速な拡大は、主に認知症の有病率の高さ、世界人口の高齢化、新しい治療ソリューションに重点を置いた研究開発（R&D）イニシアチブの増加によって推進されています。認知症の負担が増大し続ける中、世界中の政府や医療機関は、診断、治療へのアクセス、患者啓発プログラムを強化する取り組みを強化しています。
世界保健機関（WHO）によると、2023年には世界中で5,500万人以上が認知症と診断され、2030年までに7,800万人、2050年までに1億3,900万人に増加すると予測されています。革新的な医薬品の導入と臨床研究に対する政府支援資金により、市場拡大がさらに促進されています。たとえば、2023年7月、米国食品医薬品局（FDA）は、エーザイ株式会社（Eisai Co., Ltd.）が開発したアルツハイマー病治療薬であるLeqembi（レカネマブ）を認知機能の低下を遅らせる目的で承認しました。同様に、2023年12月に発表された米国保健福祉省（HHS）の認知症ケアのロードマップなどの政府の取り組みは、研究支援と治療のアクセシビリティを重視しています。
抗アミロイド抗体などの次世代治療法の開発は、認知症治療市場における変革のトレンドとして浮上しています。有望な薬剤候補であるレカネマブとドナネマブは、18カ月の治療後、認知機能低下がそれぞれ27%と35%減少したことを実証しています。さらに、フェーズ1、フェーズ2、フェーズ3の臨床試験の強力なパイプラインが、製薬開発者や投資家の間で引き続き楽観的な見通しを後押ししています。
地域別で見ると、2023年には北アメリカが世界市場を支配し、総収益の37.6%を占めました。この優位性は、疾病負担の高さ、主要な市場プレーヤーの強力な存在、確立された医療インフラに起因しています。ヨーロッパはそれに続き、ドイツ、フランス、イギリスなどの国が認知症研究に多額の投資を行っています。一方、アジア太平洋地域は、医療施設の拡大、意識向上プログラムの増加、高齢者人口の増加に支えられ、9.5%という最も高いCAGRが見込まれています。
目次
Table of Contents
Chapter 1. Global Dementia Treatment Market Executive Summary
1.1. Global Dementia Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Indication
1.3.2. By Drug Class
1.3.3. By Route of Administration
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Dementia Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Dementia Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Rising Geriatric Population
3.1.2. Increasing Prevalence of Dementia
3.1.3. Advancements in Drug Discovery & Approvals
3.2. Market Challenges
3.2.1. High Costs of Dementia Medications
3.2.2. Complexity in Clinical Trials & Drug Development
3.3. Market Opportunities
3.3.1. Government Initiatives & Funding
3.3.2. Expansion of Telemedicine & Online Pharmacies
Chapter 4. Global Dementia Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Dementia Treatment Market Size & Forecasts by Indication (2022-2032)
5.1. Segment Dashboard
5.2. Global Dementia Treatment Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Alzheimer’s Disease Dementia
5.2.2. Vascular Dementia
5.2.3. Lewy Body Dementia
5.2.4. Frontotemporal Dementia
5.2.5. Parkinson Disease Dementia
5.2.6. Others
Chapter 6. Global Dementia Treatment Market Size & Forecasts by Drug Class (2022-2032)
6.1. Segment Dashboard
6.2. Global Dementia Treatment Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cholinesterase Inhibitors
6.2.2. NMDA Receptor Antagonists
6.2.3. MAO Inhibitors
6.2.4. Combination Drug
6.2.5. Others
Chapter 7. Global Dementia Treatment Market Size & Forecasts by Route of Administration (2022-2032)
7.1. Segment Dashboard
7.2. Global Dementia Treatment Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. Transdermal Patch
7.2.3. Injectable
Chapter 8. Global Dementia Treatment Market Size & Forecasts by Distribution Channel (2022-2032)
8.1. Segment Dashboard
8.2. Global Dementia Treatment Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospital Pharmacy
8.2.2. Retail Pharmacy
8.2.3. Online Pharmacy
Chapter 9. Global Dementia Treatment Market Size & Forecasts by Region (2022-2032)
9.1. North America Dementia Treatment Market
9.1.1. U.S. Dementia Treatment Market
9.1.2. Canada Dementia Treatment Market
9.2. Europe Dementia Treatment Market
9.2.1. U.K. Dementia Treatment Market
9.2.2. Germany Dementia Treatment Market
9.2.3. France Dementia Treatment Market
9.2.4. Spain Dementia Treatment Market
9.2.5. Italy Dementia Treatment Market
9.2.6. Rest of Europe Dementia Treatment Market
9.3. Asia-Pacific Dementia Treatment Market
9.3.1. China Dementia Treatment Market
9.3.2. India Dementia Treatment Market
9.3.3. Japan Dementia Treatment Market
9.3.4. Australia Dementia Treatment Market
9.3.5. South Korea Dementia Treatment Market
9.3.6. Rest of Asia Pacific Dementia Treatment Market
9.4. Latin America Dementia Treatment Market
9.4.1. Brazil Dementia Treatment Market
9.4.2. Mexico Dementia Treatment Market
9.4.3. Rest of Latin America Dementia Treatment Market
9.5. Middle East & Africa Dementia Treatment Market
9.5.1. Saudi Arabia Dementia Treatment Market
9.5.2. South Africa Dementia Treatment Market
9.5.3. Rest of Middle East & Africa Dementia Treatment Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Eisai Co., Ltd.
10.1.2. Eli Lilly and Company
10.1.3. Biogen
10.2. Top Market Strategies
10.3. Company Profiles
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
1. Global Dementia Treatment Market, Report Scope
2. Global Dementia Treatment Market Estimates & Forecasts by Region 2022-2032 (USD Billion)
3. Global Dementia Treatment Market Estimates & Forecasts by Indication 2022-2032 (USD Billion)
4. Global Dementia Treatment Market Estimates & Forecasts by Drug Class 2022-2032 (USD Billion)
5. Global Dementia Treatment Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Billion)
6. Global Dementia Treatment Market Estimates & Forecasts by Distribution Channel 2022-2032 (USD Billion)
7. Regional Breakdown of Dementia Prevalence (2022-2032) (Million People)
8. Government Initiatives for Dementia Awareness and Treatment (2022-2032)
9. Key Investments in Dementia Drug Development by Region (2022-2032) (USD Billion)
10. Top 10 Dementia Treatment Drugs by Revenue (2022-2032) (USD Million/Billion)
11. Comparison of Approved Dementia Drugs by Effectiveness and Safety (2022-2032)
12. Pipeline Analysis of Dementia Drugs (Phase 1, 2, and 3 Trials) (2022-2032)
13. Market Share of Leading Dementia Drug Manufacturers (2022-2032) (%)
14. Adoption Rate of Oral vs. Injectable Dementia Medications by Region (2022-2032)
15. Impact of AI & Digital Health Technologies in Dementia Treatment (2022-2032)
16. Reimbursement Policies for Dementia Drugs in Major Countries (2022-2032)
17. Growth Analysis of Online Pharmacies for Dementia Drug Sales (2022-2032) (%)
18. Prevalence of Alzheimer’s Disease Dementia vs. Other Dementia Types (2022-2032) (%)
19. Key Mergers & Acquisitions in the Dementia Treatment Market (2022-2032)
20. Research & Development Spending by Major Players (2022-2032) (USD Billion)
(This list is not complete, the final report contains more than 100 tables. The list may be updated in the final deliverable.)
List of Figures
1. Global Dementia Treatment Market, Research Methodology
2. Global Dementia Treatment Market, Market Estimation Techniques
3. Dementia Prevalence by Age Group (2022-2032) (%)
4. Dementia Cases per 100,000 People by Region (2022-2032)
5. Growth Prospects of the Dementia Treatment Market (2022-2032) (USD Billion)
6. Porter’s Five Forces Analysis of the Dementia Treatment Industry
7. PESTEL Analysis of the Dementia Treatment Market
8. Global Dementia Drug Market by Type (Cholinesterase Inhibitors, NMDA Antagonists, Others) (2022-2032) (%)
9. Breakdown of Dementia Drug Market by Route of Administration (2022-2032) (%)
10. Comparison of Market Share of Dementia Drugs in North America, Europe, APAC, and LATAM (2022-2032) (%)
11. Dementia Drug Approvals in the Last Five Years (2020-2025)
12. Revenue Forecast for Major Players in the Dementia Treatment Market (2022-2032) (USD Billion)
13. Number of Clinical Trials for Dementia Drugs by Phase (2022-2032)
14. Projected Demand for New Dementia Treatment Solutions (2022-2032) (USD Billion)
15. Dementia Treatment Costs by Region (2022-2032) (USD Million/Billion)
16. Breakdown of Hospital Pharmacy vs. Retail Pharmacy Sales for Dementia Drugs (2022-2032) (%)
17. Geographic Expansion Strategies of Major Dementia Drug Manufacturers (2022-2032)
18. Key Strategic Alliances in the Dementia Drug Industry (2022-2032)
19. Impact of AI & Machine Learning in Dementia Diagnosis & Treatment (2022-2032)
20. Regulatory Approvals Timeline for Dementia Drugs in Key Markets (2022-2032)
(This list is not complete, the final report contains more than 50 figures. The list may be updated in the final deliverable.)
